NCT05462366 Omics Sequencing of Specimen Derived From Mother-Infant-Pairs
| NCT ID | NCT05462366 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhujiang Hospital |
| Condition | Healthy |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-06-22 |
| Primary Completion | 2024-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2021-06-22 with a primary completion date of 2024-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to collect breast-milk and feces from the participants, and apply culture techniques as well as omics sequencing technology to probe into the microbial and metabolomic signature of the specimens.
Eligibility Criteria
Inclusion Criteria: * healthy pregnant women aged between 20y and 40y. * Vaginal birth * BMI\<23.5 before pregnancy * Infants' birth weight, between 2500g and 4000g. Exclusion Criteria: * gestational diabetes * diagnosis of depressive disorder during pregnancy * gestational hypertension * diagnosis of other diseases during pregnancy * Under probiotics or antibiotic treatment from 3 months prior to pregnancy till 3 months after delivery * histrory of smoking and drinking alcohol * history of diarrhea from 3 months prior to pregnancy till 3 months after delivery
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05462366 clinical trial?
This trial is open to participants of all sexes, up to 40 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05462366 currently recruiting?
Yes, NCT05462366 is actively recruiting participants. Contact the research team at mayingwuzhuoyi@126.com for enrollment information.
Where is the NCT05462366 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT05462366 clinical trial?
NCT05462366 is sponsored by Zhujiang Hospital. The trial plans to enroll 100 participants.